Groupe Vicenne obtained approval from Morocco's Capital Market Authority (AMMC) on June 18, 2025, for its initial public offering on the Casablanca Stock Exchange, the company announced on Thursday. The initial public offering (IPO), the company's first sale of shares to public investors, is valued at 500 million MAD and will be conducted through a capital increase reserved for the public. Share subscriptions are scheduled from June 30 to July 4, 2025, with shares priced at 236 MAD each. Vicenne operates as a major supplier of high-tech equipment, solutions, and services to healthcare professionals in Morocco, serving hospitals, clinics, medical offices, laboratories, and the Ministry of Health. The company expanded internationally to Senegal in 2018 and Côte d'Ivoire in 2021. The group specializes in high-value segments, including heavy medical equipment, implantable medical devices, in vitro diagnostics, and medical waste management. It maintains partnerships with international suppliers, including Elekta, Philips Medical Solutions, Mindray, Abbott, and Beckman Coulter. Since 2020, Vicenne has pursued strategic diversification through external growth, acquiring majority stakes in Mabiotech in 2020 and Saiss Environnement in 2022. The company serves over 1,800 active clients with a portfolio exceeding 25,000 medical equipment references and 185,000 medical device references.
